Mühleder, Severin
Pill, Karoline
Schaupper, Mira
Labuda, Krystyna
Priglinger, Eleni
Hofbauer, Pablo
Charwat, Verena
Marx, Uwe
Redl, Heinz
Holnthoner, Wolfgang
Funding for this research was provided by:
Österreichische Forschungsförderungsgesellschaft (845290)
Article History
Received: 4 May 2017
Revised: 22 November 2017
Accepted: 26 December 2017
First Online: 12 February 2018
Change Date: 30 September 2018
Change Type: Correction
Change Details: The original article [1] contains numerous value errors in the graphs in Fig. 2b regarding the markers describing the values for total tubule length and mean tubule length without aprotinin at 2.5 mg/ml concentration of fibrinogen. The corrected version of this figure can be viewed ahead.
Ethics approval and consent to participate
: ECFC and ASC were isolated from biologic materials obtained from healthy donors with approval of local ethics committees (ethics votum #1/2012 for the isolation of ECFC approved by AUVA (Allgemeine Unfallversicherungsanstalt - the Austrian Workers' Compensation Board) and #200 for ASC approved by Ethikkommission des Landes Oberösterreich) in accordance with the relevant guidelines and regulations and after obtaining informed consent from the donor.
: Not applicable.
: Dr. Uwe Marx is CEO and shareholder of the TissUse GmbH, Germany. All other authors declare that they have no competing interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.